If you find your mind racing from everyday routine concerns, or you are feeling the weight of the world on your shoulders, you are not alone. Many of us have recently had to make unprecedented changes to our lives...
Depression can be a complex condition to effectively treat. Antidepressant medications are often prescribed to manage depression symptoms, but unfortunately, some patients do not experience relief from medication. These patients after several trials, may in turn have “treatment resistant...
Transcranial magnetic stimulation (TMS) is a type of brain stimulation therapy that has four different subtypes, or modalities. That is, there are four different manners in which TMS is administered. The four methods are: 1) Single-pulse TMS, 2) Repetitive...
Contrary to the name, transcranial magnetic stimulation, or TMS is actually a type of neuromodulation rather than stimulation. That is, when TMS therapy is administered, the goal is to change, or modulate brain function by either stimulating or inhibiting...
The thought of having your brain stimulated may bring some feelings of uncertainly, but let’s clarify the facts about TMS. While not an exhaustive list, below are some clarifications for some of the most common misconceptions about TMS: Misconception:...
This post focuses on some of the non-medicine treatments of Postural Tachycardia Syndrome (POTS) and why they are effective. When we stand, gravity pulls blood down, away from the heart. Since blood must return to the heart in order...
The history of using brain stimulation to treat patients, particularly patients in psychiatric hospitals, dates back many years. Back in the nineteenth century, electroconvulsive therapy (better known as ECT) was a commonly used method of treatment. Before the technique...
Psychiatric disorders affect children in their abilities to learn, behave, and adapt to dealing with daily stressors. According to the Centers for Disease Control and Prevention, an estimated 1 in 6 children between the ages of 2 through 8...
Ketamine is a N-methyl-D-aspartate (NMDA) receptor antagonist that was approved by the FDA in 1970 as an anesthetic agent for diagnostic and surgical procedures that do not require skeletal muscle relaxation. Recently, we discussed a new formulation of the...
In March 2019, the Food and Drug Administration approved esketamine (SPRAVATO™) nasal spray to be used in conjunction with an oral antidepressant, for the treatment of treatment-resistant depression (TRD) in adults.¹ TRD affects almost one-third of patients with depression...